Paul Brooks

In this online exclusive, Paul Brooks, executive director, Regulatory Affairs Professionals Society (RAPS), looks at the impact Brexit may have on the healthcare product regulatory space and how clarity is urgently needed. Read more


Last week, the UK government saw heated debates and closely contested votes on the post-Brexit strategy, including a favourable outcome for the future relationship of the UK and the European Medicines Agency (EMA) Read more